Wound Treatments in the US

Sector sales growth in wound treatments slowed to 2% in 2008, following strong mid to high single-digit increases in 2006 and 2007. The slowing US economy has undermined the performance of premium value-added sticking plasters, which have previously been responsible for the bulk of sector growth. Consumers looking for treatments for minor cuts and scratches are increasingly turning to private label brands that are comparable to national names, like Band-Aid, but are often priced about 30% cheaper, on a per unit basis.

The wound treatments sector is very mature. For example, the ubiquitous sticking plaster, known generically as a “Band-Aid” has been around for more than 80 years. Despite the maturity of the sector, growth has historically remained strong, as branded players have actively promoted their products and launched incremental product innovations, such as making plasters that are stickier, more visually appealing, target specific body parts or are convenient to use.

Wound Treatments in the US report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market- be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage: sticking plasters, other wound treatments

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?

- Get a detailed picture of the wound treatments industry
- Identify growth sectors and factors driving change
- Understand the competitive environment, the market’s major players and leading brands
- Use five-year forecasts to assess how the market is predicted to develop SHOW LESS READ MORE >

Wound Treatments in the US
Euromonitor International
March 2009
List of Contents and Tables
Executive Summary
OTC Industry Proves Recession Resistant
Fusion of Standard and Herbal Medicine Emerges
Private Label Gains Share
Retailers Focus on Consumer Health
Industry Growth Is Expected To Remain Dynamic
Key Trends and Developments
America Is Becoming Less Healthy
Fusion of Standard and Natural Medicine
Behind-the-counter Category Emerges
US Economic Slowdown Promotes Self-medication
Private Label Proves To Be A Tenacious Competitor
Vitamins and Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
Switches
Summary 1 OTC Healthcare Switches 2005-2007
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
Market Data
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Penetration of Private Label by Sector 2003-2008
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
Definitions
Summary 2 Research Sources
Adams Respiratory Therapeutics Inc
Strategic Direction
Key Facts
Summary 3 Adams Respiratory Therapeutics Inc: Key Facts
Company Background
Production
Competitive Positioning
Summary 4 Adams Respiratory Therapeutics Inc: Competitive Position 2008
Bayer Corp
Strategic Direction
Key Facts
Summary 5 Bayer Corp: Key Facts
Company Background
Competitive Positioning
Summary 6 Bayer Corp: Competitive Position 2008
Chattem Inc
Strategic Direction
Key Facts
Summary 7 Chattem Inc: Key Facts
Summary 8 Chattem Inc: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 9 Chattem Inc: Competitive Position 2008
General Nutrition Centers Inc
Strategic Direction
Key Facts
Summary 10 General Nutrition Centers Inc: Key Facts
Summary 11 General Nutrition Centers Inc: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 12 General Nutrition Centers Inc: Competitive Position 2008
GlaxoSmithKline Consumer Health
Strategic Direction
Key Facts
Summary 13 GlaxoSmithKline: Key Facts
Company Background
Production
Competitive Positioning
Summary 14 GlaxoSmithKline: Competitive Position 2008
Johnson & Johnson Inc
Strategic Direction
Key Facts
Summary 15 Johnson & Johnson Inc: Key Facts
Company Background
Production
Competitive Positioning
Summary 16 McNeil Consumer & Specialty Pharmaceuticals: Competitive Position 2008
Summary 17 Pfizer Consumer Healthcare Ltd: Competitive Position 2008
Summary 18 Johnson & Johnson Consumer Products Inc: Competitive Position 2008
Summary 19 Advanced Care Products: Competitive Position 2008
Summary 20 Neutrogena: Competitive Position 2008
Mannatech Inc
Strategic Direction
Key Facts
Summary 21 Mannatech Inc: Key Facts
Summary 22 Mannatech Inc: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 23 Mannatech Inc: Competitive Position 2008
Melaleuca Inc
Strategic Direction
Key Facts
Summary 24 Melaleuca Inc: Key Facts
Summary 25 Melaleuca Inc: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 26 Melaleuca Inc: Competitive Position 2008
Procter & Gamble Co, the
Strategic Direction
Key Facts
Summary 27 Procter & Gamble: Key Facts
Company Background
Production
Competitive Positioning
Summary 28 Procter & Gamble: Competitive Position 2008
Wyeth Consumer Healthcare Inc
Strategic Direction
Key Facts
Summary 29 Wyeth Consumer Healthcare: Key Facts
Summary 30 Wyeth Consumer Healthcare: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 31 Wyeth Consumer Healthcare: Competitive Position 2008
Trends
Sector Data
Table 12 Sales of Wound Treatments by Subsector: Value 2003-2008
Table 13 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
Table 14 Wound Treatments Company Shares by Value 2004-2008
Table 15 Wound Treatments Brand Shares by Value 2005-2008
Table 16 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
Table 17 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013

- Wyeth Consumer Healthcare

- Adams Respiratory Therapeutics Inc

- General Nutrition Centers Inc

- Mannatech Inc

- Forever Living Products LLC

- Chattem Inc

- McNeil Consumer & Specialty Pharmaceuticals

- NBTY Inc

- The Procter & Gamble Co